,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1452277,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,30,ACAA1,https://ctdbase.org/detail.go?type=gene&acc=30,,,30,ACAA1,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACAA1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
1,1452278,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449,ACAA2,9606,Homo sapiens (human),Farnesol analog results in increased expression of ACAA2 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of ACAA2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
2,1452279,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34,ACADM,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACADM mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
3,1452280,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,35,ACADS,https://ctdbase.org/detail.go?type=gene&acc=35,,,35,ACADS,9606,Homo sapiens (human),Farnesol analog results in increased expression of ACADS mrna|[farnesol analog co-treated with oleic acid] results in increased expression of ACADS mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4,1452281,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,38,ACAT1,https://ctdbase.org/detail.go?type=gene&acc=38,,,38,ACAT1,9606,Homo sapiens (human),Farnesol analog results in increased expression of ACAT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
5,1452282,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,39,ACAT2,https://ctdbase.org/detail.go?type=gene&acc=39,,,39,ACAT2,9606,Homo sapiens (human),Farnesol analog results in increased expression of ACAT2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
6,1452283,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,641371,ACOT1,https://ctdbase.org/detail.go?type=gene&acc=641371,,,641371,ACOT1,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACOT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
7,1452284,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,134526,ACOT12,https://ctdbase.org/detail.go?type=gene&acc=134526,,,134526,ACOT12,9606,Homo sapiens (human),Farnesol analog results in increased expression of ACOT12 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of ACOT12 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
8,1452285,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,641372,ACOT6,https://ctdbase.org/detail.go?type=gene&acc=641372,,,641372,ACOT6,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of ACOT6 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
9,1452475,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51,ACOX1,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACOX1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
10,1452476,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,8309,ACOX2,https://ctdbase.org/detail.go?type=gene&acc=8309,,,8309,ACOX2,9606,Homo sapiens (human),Farnesol analog results in increased expression of ACOX2 mrna|farnesol analog results in decreased expression of ACOX2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
11,1452477,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2182,ACSL4,https://ctdbase.org/detail.go?type=gene&acc=2182,,,2182,ACSL4,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACSL4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
12,1452478,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,51703,ACSL5,https://ctdbase.org/detail.go?type=gene&acc=51703,,,51703,ACSL5,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACSL5 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
13,1452479,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,10554,AGPAT1,https://ctdbase.org/detail.go?type=gene&acc=10554,,,10554,AGPAT1,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of AGPAT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
14,1452480,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016,AKR1B10,9606,Homo sapiens (human),AKR1B10 protein results in increased chemical synthesis of farnesol,,,PMID:21187079,https://www.ncbi.nlm.nih.gov/pubmed/21187079,21187079,,
15,1452481,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645,AKR1C1,9606,Homo sapiens (human),Farnesol results in increased expression of AKR1C1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
16,1452482,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644,AKR1C3,9606,Homo sapiens (human),[tolfenamic acid results in decreased activity of AKR1C3 protein] which results in increased metabolism of farnesol|[flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased metabolism of farnesol|akr1c3 protein results in increased chemical synthesis of farnesol,,,PMID:21187079,https://www.ncbi.nlm.nih.gov/pubmed/21187079,21187079,,
17,1452483,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,116519,APOA5,https://ctdbase.org/detail.go?type=gene&acc=116519,,,116519,APOA5,9606,Homo sapiens (human),Farnesol analog results in increased expression of APOA5 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of APOA5 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
18,1452484,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,346,APOC4,https://ctdbase.org/detail.go?type=gene&acc=346,,,346,APOC4,9606,Homo sapiens (human),Farnesol analog results in decreased expression of APOC4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
19,1452671,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467,ATF3,9606,Homo sapiens (human),Farnesol results in increased expression of ATF3 mRNA,,,PMID:27965148,https://www.ncbi.nlm.nih.gov/pubmed/27965148,27965148,,
20,1452672,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578,BAK1,9606,Homo sapiens (human),Farnesol results in increased expression of BAK1 protein,,,PMID:12530055,https://www.ncbi.nlm.nih.gov/pubmed/12530055,12530055,,
21,1452673,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Farnesol results in increased activity of CASP3 protein,,,PMID:10733934,https://www.ncbi.nlm.nih.gov/pubmed/10733934,10733934,,
22,1452674,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10116,Rattus norvegicus (Norway rat),Farnesol results in decreased activity of CASP3 protein,,,PMID:21453689,https://www.ncbi.nlm.nih.gov/pubmed/21453689,21453689,,
23,1452675,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10090,Mus musculus (house mouse),Farnesol inhibits the reaction [acetaminophen results in decreased activity of CAT protein],,,PMID:37458150,https://www.ncbi.nlm.nih.gov/pubmed/37458150,37458150,,
24,1452676,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Farnesol inhibits the reaction [tobacco smoke pollution results in decreased activity of CAT protein],,,PMID:18793622,https://www.ncbi.nlm.nih.gov/pubmed/18793622,18793622,,
25,1452677,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Farnesol results in increased expression of CAT protein,,,PMID:21453689,https://www.ncbi.nlm.nih.gov/pubmed/21453689,21453689,,
26,1452678,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,6351,CCL4,https://ctdbase.org/detail.go?type=gene&acc=6351,,,6351,CCL4,9606,Homo sapiens (human),Farnesol results in increased secretion of CCL4 protein,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
27,1452679,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890,CCNA2,9606,Homo sapiens (human),Farnesol results in decreased expression of CCNA2 protein,,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
28,1452680,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891,CCNB1,9606,Homo sapiens (human),Farnesol results in decreased expression of CCNB1 protein,,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
29,1452681,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017,CDK2,9606,Homo sapiens (human),Farnesol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]|farnesol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]|farnesol results in decreased expression of CDK2 protein,,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
30,1452867,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,9606,Homo sapiens (human),Farnesol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein]|farnesol results in increased expression of CDKN1A protein|cdkn1a protein results in increased susceptibility to farnesol,,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
31,1452868,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027,CDKN1B,9606,Homo sapiens (human),CDKN1B protein results in increased susceptibility to farnesol|farnesol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]|farnesol results in increased expression of CDKN1B protein,,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
32,1452869,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1352,COX10,https://ctdbase.org/detail.go?type=gene&acc=1352,,,1352,COX10,9606,Homo sapiens (human),Farnesol analog results in decreased expression of COX10 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
33,1452870,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374,CPT1A,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of CPT1A mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
34,1452871,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),Farnesol results in increased expression of CXCL8 mRNA,,,PMID:27965148|PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/27965148|https://www.ncbi.nlm.nih.gov/pubmed/30806763,27965148|30806763,,
35,1452872,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),Farnesol results in increased secretion of CXCL8 protein,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
36,1452873,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588,CYP19A1,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP19A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
37,1452874,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543,CYP1A1,9606,Homo sapiens (human),Farnesol results in increased expression of CYP1A1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
38,1452875,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543,CYP1A1,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP1A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
39,1452876,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544,CYP1A2,9606,Homo sapiens (human),Farnesol analog inhibits the reaction [oleic acid results in decreased expression of CYP1A2 mrna],,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
40,1453024,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544,CYP1A2,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP1A2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
41,1453025,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,57404,CYP20A1,https://ctdbase.org/detail.go?type=gene&acc=57404,,,57404,CYP20A1,7955,Danio rerio (zebrafish),Farnesol results in increased expression of CYP20A1 mRNA,,,PMID:26853319,https://www.ncbi.nlm.nih.gov/pubmed/26853319,26853319,,
42,1453026,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24894,CYP2A1,https://ctdbase.org/detail.go?type=gene&acc=24894,,,24894,Cyp2a1,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
43,1453027,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24895,CYP2A2,https://ctdbase.org/detail.go?type=gene&acc=24895,,,24895,Cyp2a2,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2A2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
44,1453028,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24299,CYP2A3,https://ctdbase.org/detail.go?type=gene&acc=24299,,,24299,Cyp2a3,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2A3 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
45,1453029,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300,Cyp2b1,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2B1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
46,1453030,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,361523,CYP2B2,https://ctdbase.org/detail.go?type=gene&acc=361523,,,361523,Cyp2b2,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2B2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
47,1453031,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555,CYP2B6,9606,Homo sapiens (human),Farnesol analog inhibits the reaction [oleic acid results in decreased expression of CYP2B6 mrna]|farnesol analog results in increased expression of CYP2B6 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of CYP2B6 mrna|farnesol results in increased expression of CYP2B6 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
48,1453032,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,100328933,CYP2C,https://ctdbase.org/detail.go?type=gene&acc=100328933,,,100328933,CYP2C,9606,Homo sapiens (human),Farnesol results in increased expression of CYP2C mRNA,,,PMID:15629189,https://www.ncbi.nlm.nih.gov/pubmed/15629189,15629189,,
49,1453033,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,29277,CYP2C11,https://ctdbase.org/detail.go?type=gene&acc=29277,,,29277,Cyp2c11,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2C11 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
50,1453200,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,25011,CYP2C12,https://ctdbase.org/detail.go?type=gene&acc=25011,,,25011,Cyp2c12,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2C12 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
51,1453201,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571,CYP2E1,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of CYP2E1 mrna|farnesol analog inhibits the reaction [oleic acid results in increased expression of CYP2E1 mrna]|farnesol results in decreased expression of CYP2E1 mrna|farnesol analog results in decreased expression of CYP2E1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
52,1453202,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571,CYP2E1,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2E1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
53,1453203,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682,Cyp3a2,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP3A2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
54,1453204,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642,Cyp3a23-3a1,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP3A23-3A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
55,1453205,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,9606,Homo sapiens (human),Farnesol analog inhibits the reaction [oleic acid results in decreased expression of CYP3A4 mrna]|farnesol results in increased expression of CYP3A4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
56,1453206,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,50549,CYP4A1,https://ctdbase.org/detail.go?type=gene&acc=50549,,,50549,Cyp4a1,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP4A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
57,1453207,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24306,CYP4A2,https://ctdbase.org/detail.go?type=gene&acc=24306,,,24306,Cyp4a2,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP4A2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
58,1453208,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,298423,CYP4A3,https://ctdbase.org/detail.go?type=gene&acc=298423,,,298423,Cyp4a3,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP4A3 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
59,1453209,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1666,DECR1,https://ctdbase.org/detail.go?type=gene&acc=1666,,,1666,DECR1,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of DECR1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
60,1453393,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,8694,DGAT1,https://ctdbase.org/detail.go?type=gene&acc=8694,,,8694,DGAT1,9606,Homo sapiens (human),Farnesol analog results in decreased expression of DGAT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
61,1453394,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649,DGAT2,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of DGAT2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
62,1453395,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,11080,DNAJB4,https://ctdbase.org/detail.go?type=gene&acc=11080,,,11080,DNAJB4,9606,Homo sapiens (human),Farnesol results in increased expression of DNAJB4 mRNA,,,PMID:27965148,https://www.ncbi.nlm.nih.gov/pubmed/27965148,27965148,,
63,1453396,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1891,ECH1,https://ctdbase.org/detail.go?type=gene&acc=1891,,,1891,ECH1,9606,Homo sapiens (human),Farnesol analog results in increased expression of ECH1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
64,1453397,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950,EGF,9606,Homo sapiens (human),Farnesol analog results in decreased susceptibility to [INS protein co-treated with EGF protein]|farnesol analog inhibits the reaction [EGF protein results in increased activity of RHOA protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
65,1453398,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071,ELOVL6,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ELOVL6 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
66,1453399,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168,FABP1,9606,Homo sapiens (human),Farnesol analog results in increased expression of FABP1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
67,1453400,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167,FABP4,9606,Homo sapiens (human),Farnesol results in increased expression of FABP4 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
68,1453401,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194,FASN,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of FASN mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
69,1453402,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222,FDFT1,9606,Homo sapiens (human),Farnesol analog results in increased expression of FDFT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
70,1453403,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2339,FNTA,https://ctdbase.org/detail.go?type=gene&acc=2339,,,2339,FNTA,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of FNTA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
71,1453593,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2342,FNTB,https://ctdbase.org/detail.go?type=gene&acc=2342,,,2342,FNTB,9606,Homo sapiens (human),Farnesol analog results in decreased expression of FNTB mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
72,1453594,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,137964,GPAT4,https://ctdbase.org/detail.go?type=gene&acc=137964,,,137964,GPAT4,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of GPAT4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
73,1453595,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875,GPT,10090,Mus musculus (house mouse),Farnesol inhibits the reaction [acetaminophen results in increased expression of GPT protein],,,PMID:37458150,https://www.ncbi.nlm.nih.gov/pubmed/37458150,37458150,,
74,1453596,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10090,Mus musculus (house mouse),Farnesol inhibits the reaction [acetaminophen results in decreased activity of GSR protein],,,PMID:37458150,https://www.ncbi.nlm.nih.gov/pubmed/37458150,37458150,,
75,1453597,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of GSR protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
76,1453598,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10116,Rattus norvegicus (Norway rat),Farnesol results in increased expression of GSR protein,,,PMID:21453689,https://www.ncbi.nlm.nih.gov/pubmed/21453689,21453689,,
77,1453599,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3030,HADHA,https://ctdbase.org/detail.go?type=gene&acc=3030,,,3030,HADHA,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of HADHA mrna|farnesol analog results in increased expression of HADHA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
78,1453600,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3032,HADHB,https://ctdbase.org/detail.go?type=gene&acc=3032,,,3032,HADHB,9606,Homo sapiens (human),Farnesol analog results in increased expression of HADHB mrna|[farnesol analog co-treated with oleic acid] results in increased expression of HADHB mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
79,1453601,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156,HMGCR,10029,Cricetulus griseus (Chinese hamster),Farnesol results in increased degradation of HMGCR protein,,,PMID:8021239,https://www.ncbi.nlm.nih.gov/pubmed/8021239,8021239,,
80,1453602,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156,HMGCR,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of HMGCR mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
81,1453793,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156,HMGCR,9606,Homo sapiens (human),Farnesol results in decreased activity of HMGCR protein,,,PMID:12477733,https://www.ncbi.nlm.nih.gov/pubmed/12477733,12477733,,
82,1453794,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156,HMGCR,10116,Rattus norvegicus (Norway rat),Farnesol results in increased expression of HMGCR protein,,,PMID:16332721,https://www.ncbi.nlm.nih.gov/pubmed/16332721,16332721,,
83,1453795,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,9606,Homo sapiens (human),Farnesol results in increased expression of HMOX1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
84,1453796,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3265,HRAS,https://ctdbase.org/detail.go?type=gene&acc=3265,,,3265,HRAS,9606,Homo sapiens (human),Farnesol inhibits the reaction [simvastatin results in decreased farnesylation of and affects the localization of HRAS protein],,,PMID:12477733,https://www.ncbi.nlm.nih.gov/pubmed/12477733,12477733,,
85,1453797,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383,ICAM1,9606,Homo sapiens (human),Farnesol results in increased expression of ICAM1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
86,1453798,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551,IKBKB,10090,Mus musculus (house mouse),Farnesol inhibits the reaction [acetaminophen results in increased expression of IKBKB mrna],,,PMID:37458150,https://www.ncbi.nlm.nih.gov/pubmed/37458150,37458150,,
87,1453799,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3603,IL16,https://ctdbase.org/detail.go?type=gene&acc=3603,,,3603,IL16,9606,Homo sapiens (human),Farnesol results in increased secretion of IL16 protein,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
88,1453800,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552,IL1A,9606,Homo sapiens (human),Farnesol results in increased expression of IL1A mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
89,1453801,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),Farnesol inhibits the reaction [[alendronate co-treated with lipopolysaccharides] results in increased expression of IL1B protein]|farnesol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to lipopolysaccharides] which results in increased expression of IL1B protein],,,PMID:20304105,https://www.ncbi.nlm.nih.gov/pubmed/20304105,20304105,,
90,1453802,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10090,Mus musculus (house mouse),Farnesol inhibits the reaction [acetaminophen results in increased expression of IL1B protein],,,PMID:37458150,https://www.ncbi.nlm.nih.gov/pubmed/37458150,37458150,,
91,1453991,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7850,IL1R2,https://ctdbase.org/detail.go?type=gene&acc=7850,,,7850,IL1R2,9606,Homo sapiens (human),Farnesol results in increased expression of IL1R2 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
92,1453992,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),Farnesol inhibits the reaction [acetaminophen results in increased expression of IL6 mrna],,,PMID:37458150,https://www.ncbi.nlm.nih.gov/pubmed/37458150,37458150,,
93,1453993,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630,INS,9606,Homo sapiens (human),Farnesol analog results in decreased susceptibility to [INS protein co-treated with EGF protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
94,1453994,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3990,LIPC,https://ctdbase.org/detail.go?type=gene&acc=3990,,,3990,LIPC,9606,Homo sapiens (human),Farnesol analog results in increased expression of LIPC mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
95,1453995,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,23175,LPIN1,https://ctdbase.org/detail.go?type=gene&acc=23175,,,23175,LPIN1,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of LPIN1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
96,1453996,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,64900,LPIN3,https://ctdbase.org/detail.go?type=gene&acc=64900,,,64900,LPIN3,9606,Homo sapiens (human),Farnesol analog results in decreased expression of LPIN3 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
97,1453997,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,51085,MLXIPL,https://ctdbase.org/detail.go?type=gene&acc=51085,,,51085,MLXIPL,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of MLXIPL mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
98,1453998,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,4314,MMP3,https://ctdbase.org/detail.go?type=gene&acc=4314,,,4314,MMP3,9606,Homo sapiens (human),Farnesol results in increased expression of MMP3 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
99,1453999,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598,MVK,9606,Homo sapiens (human),Farnesol inhibits the reaction [MVK gene mutant form results in increased susceptibility to lipopolysaccharides]|farnesol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to lipopolysaccharides] which results in increased expression of IL1B protein],,,PMID:20304105,https://www.ncbi.nlm.nih.gov/pubmed/20304105,20304105,,
100,1454000,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598,MVK,9606,Homo sapiens (human),Farnesol results in decreased activity of MVK protein|farnesol inhibits the reaction [MVK protein results in increased phosphorylation of mevalonic acid]|farnesol inhibits the reaction [MVK protein results in increased hydrolysis of adenosine triphosphate],,,PMID:9392419,https://www.ncbi.nlm.nih.gov/pubmed/9392419,9392419,,
101,1454193,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,10398,MYL9,https://ctdbase.org/detail.go?type=gene&acc=10398,,,10398,MYL9,9606,Homo sapiens (human),Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MYL9 protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
102,1454194,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,10116,Rattus norvegicus (Norway rat),Farnesol results in increased activity of NQO1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
103,1454195,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,8431,NR0B2,https://ctdbase.org/detail.go?type=gene&acc=8431,,,8431,NR0B2,9606,Homo sapiens (human),Farnesol analog results in decreased expression of NR0B2 mrna|[farnesol analog co-treated with oleic acid] results in decreased expression of NR0B2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
104,1454196,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971,NR1H4,9606,Homo sapiens (human),Farnesol analog results in decreased expression of NR1H4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
105,1454197,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971,NR1H4,9606,Homo sapiens (human),Farnesol binds to and results in increased activity of NR1H4 protein,,,PMID:15491415,https://www.ncbi.nlm.nih.gov/pubmed/15491415,15491415,,
106,1454198,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971,NR1H4,47144,Tetraodon,Farnesol analog binds to and results in increased activity of NR1H4 protein|farnesol binds to and results in increased activity of NR1H4 protein,,,PMID:21291553,https://www.ncbi.nlm.nih.gov/pubmed/21291553,21291553,,
107,1454199,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105,PCK1,9606,Homo sapiens (human),Farnesol analog results in decreased expression of PCK1 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of PCK1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
108,1454200,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,23590,PDSS1,https://ctdbase.org/detail.go?type=gene&acc=23590,,,23590,PDSS1,9606,Homo sapiens (human),Farnesol analog results in increased expression of PDSS1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
109,1454201,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123,PLIN2,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of PLIN2 mrna|farnesol analog results in increased expression of PLIN2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
110,1454202,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465,PPARA,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of PPARA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
111,1454397,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465,PPARA,9606,Homo sapiens (human),Farnesol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
112,1454398,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,9606,Homo sapiens (human),Farnesol analog results in increased expression of PPARG mrna|[farnesol analog co-treated with oleic acid] results in increased expression of PPARG mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
113,1454399,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,10116,Rattus norvegicus (Norway rat),Farnesol inhibits the reaction [atorvastatin inhibits the reaction [TNF protein results in decreased expression of PPARGC1A protein]],,,PMID:22343369,https://www.ncbi.nlm.nih.gov/pubmed/22343369,22343369,,
114,1454400,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5875,RABGGTA,https://ctdbase.org/detail.go?type=gene&acc=5875,,,5875,RABGGTA,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of RABGGTA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
115,1454401,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5876,RABGGTB,https://ctdbase.org/detail.go?type=gene&acc=5876,,,5876,RABGGTB,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of RABGGTB mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
116,1454402,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387,RHOA,9606,Homo sapiens (human),Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOA protein]|farnesol analog inhibits the reaction [EGF protein results in increased activity of RHOA protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
117,1454403,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387,RHOA,10116,Rattus norvegicus (Norway rat),Farnesol inhibits the reaction [lovastatin affects the localization of RHOA protein],,,PMID:9398081,https://www.ncbi.nlm.nih.gov/pubmed/9398081,9398081,,
118,1454404,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,389,RHOC,https://ctdbase.org/detail.go?type=gene&acc=389,,,389,RHOC,9606,Homo sapiens (human),Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
119,1454405,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256,RXRA,9606,Homo sapiens (human),Farnesol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
120,1454406,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319,SCD,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of SCD mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
121,1454601,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,79966,SCD5,https://ctdbase.org/detail.go?type=gene&acc=79966,,,79966,SCD5,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of SCD5 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
122,1454602,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,6317,SERPINB3,https://ctdbase.org/detail.go?type=gene&acc=6317,,,6317,SERPINB3,9606,Homo sapiens (human),Farnesol results in increased expression of SERPINB3 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
123,1454603,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,788,SLC25A20,https://ctdbase.org/detail.go?type=gene&acc=788,,,788,SLC25A20,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of SLC25A20 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
124,1454604,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,376497,SLC27A1,https://ctdbase.org/detail.go?type=gene&acc=376497,,,376497,SLC27A1,9606,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of SLC27A1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
125,1454605,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,11001,SLC27A2,https://ctdbase.org/detail.go?type=gene&acc=11001,,,11001,SLC27A2,9606,Homo sapiens (human),Farnesol analog results in increased expression of SLC27A2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
126,1454606,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,23657,SLC7A11,https://ctdbase.org/detail.go?type=gene&acc=23657,,,23657,SLC7A11,9606,Homo sapiens (human),Farnesol results in increased expression of SLC7A11 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
127,1454607,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,9606,Homo sapiens (human),Farnesol results in increased expression of TNF mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
128,1454608,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10090,Mus musculus (house mouse),Farnesol inhibits the reaction [acetaminophen results in increased expression of TNF protein],,,PMID:37458150,https://www.ncbi.nlm.nih.gov/pubmed/37458150,37458150,,
129,1454609,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),Farnesol inhibits the reaction [atorvastatin inhibits the reaction [TNF protein results in decreased expression of PPARGC1A protein]],,,PMID:22343369,https://www.ncbi.nlm.nih.gov/pubmed/22343369,22343369,,
130,1454610,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658,UGT1A1,9606,Homo sapiens (human),UGT1A1 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
131,1454611,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54659,UGT1A3,https://ctdbase.org/detail.go?type=gene&acc=54659,,,54659,UGT1A3,9606,Homo sapiens (human),UGT1A3 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
132,1454804,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54657,UGT1A4,https://ctdbase.org/detail.go?type=gene&acc=54657,,,54657,UGT1A4,9606,Homo sapiens (human),UGT1A4 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
133,1454805,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578,UGT1A6,9606,Homo sapiens (human),UGT1A6 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
134,1454806,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600,UGT1A9,9606,Homo sapiens (human),UGT1A9 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
135,1454807,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7363,UGT2B4,https://ctdbase.org/detail.go?type=gene&acc=7363,,,7363,UGT2B4,9606,Homo sapiens (human),UGT2B4 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
136,1454808,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7364,UGT2B7,https://ctdbase.org/detail.go?type=gene&acc=7364,,,7364,UGT2B7,9606,Homo sapiens (human),UGT2B7 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
137,1553661,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,1238,Amine oxidase [flavin-containing] B [I199F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1238,P27338,Amine oxidase [flavin-containing] B,4129,MAOB,9606,Homo sapiens (human),,Ki (nM),>1000000,PMID:15710600|DOI:10.1074/jbc.M500949200,https://www.ncbi.nlm.nih.gov/pubmed/15710600|https://doi.org/10.1074/jbc.M500949200,15710600,10.1074/jbc.M500949200,
138,1553852,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,384,Amine oxidase [flavin-containing] A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=384,P21397,Amine oxidase [flavin-containing] A,4128,MAOA,9606,Homo sapiens (human),,Ki (nM),>1000000,PMID:15710600|DOI:10.1074/jbc.M500949200,https://www.ncbi.nlm.nih.gov/pubmed/15710600|https://doi.org/10.1074/jbc.M500949200,15710600,10.1074/jbc.M500949200,
139,1553853,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,385,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=385,P27338,Amine oxidase [flavin-containing] B,4129,MAOB,9606,Homo sapiens (human),,Ki (nM),2300,PMID:15710600|DOI:10.1074/jbc.M500949200,https://www.ncbi.nlm.nih.gov/pubmed/15710600|https://doi.org/10.1074/jbc.M500949200,15710600,10.1074/jbc.M500949200,
140,1553854,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,50002008,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50002008,P56560,Amine oxidase [flavin-containing] B,338445,MAOB,9913,Bos taurus (cattle),,Ki (nM),>1000000,PMID:15710600|DOI:10.1074/jbc.M500949200,https://www.ncbi.nlm.nih.gov/pubmed/15710600|https://doi.org/10.1074/jbc.M500949200,15710600,10.1074/jbc.M500949200,
141,1553855,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,385,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=385,P27338,Amine oxidase [flavin-containing] B,4129,MAOB,9606,Homo sapiens (human),,Ki (nM),800,PMID:15710600|DOI:10.1074/jbc.M500949200,https://www.ncbi.nlm.nih.gov/pubmed/15710600|https://doi.org/10.1074/jbc.M500949200,15710600,10.1074/jbc.M500949200,
142,1553856,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,1130,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1130,P19643,Amine oxidase [flavin-containing] B,25750,Maob,10116,Rattus norvegicus (Norway rat),,Ki (nM),5000,PMID:15710600|DOI:10.1074/jbc.M500949200,https://www.ncbi.nlm.nih.gov/pubmed/15710600|https://doi.org/10.1074/jbc.M500949200,15710600,10.1074/jbc.M500949200,
143,1553857,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,50001942,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001942,Q8BW75,Amine oxidase [flavin-containing] B,109731,Maob,10090,Mus musculus (house mouse),,Ki (nM),2400,PMID:15710600|DOI:10.1074/jbc.M500949200,https://www.ncbi.nlm.nih.gov/pubmed/15710600|https://doi.org/10.1074/jbc.M500949200,15710600,10.1074/jbc.M500949200,
144,1771953,445070,Therapeutic Target Database (TTD),"trans,trans-Farnesol",D0M0CF,Farnesol,https://idrblab.net/ttd/data/drug/details/D0M0CF,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129,MAOB,9606,Homo sapiens (human),Inhibitor,,,,,,,
